Cargando…

Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway

Purpose: Functional impairment of endothelial progenitor cells (EPCs) is frequently observed in patients with diabetic vascular complications. Astragaloside IV (ASV) has a significant protective effect against vascular endothelial dysfunction. Thus, this study aimed to investigate the role of ASV on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Weibin, Cai, Xinrui, Qian, Qiuhai, Zhuang, Qianzhu, Yang, Wenjun, Zhang, Xinying, Zhao, Lijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677131/ https://www.ncbi.nlm.nih.gov/pubmed/31440038 http://dx.doi.org/10.2147/DDDT.S207774

Ejemplares similares

Astragaloside IV modulates TGF‐β1‐dependent epithelial‐mesenchymal transition in bleomycin‐induced pulmonary fibrosis
por: Qian, Weibin, et al.
Publicado: (2018)

Astragaloside IV inhibits oxidized low-density lipoprotein-induced endothelial damage via upregulation of miR-140-3p
por: Qian, Weibin, et al.
Publicado: (2019)

Astragaloside IV inhibits oxidized low-density lipoprotein-induced endothelial damage via upregulation of miR-140-3p
por: Qian, Weibin, et al.
Publicado: (2023)

Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC
por: Zhang, Wenting, et al.
Publicado: (2021)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation
por: Sun, Zhenzhen, et al.
Publicado: (2019)

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
por: Qian, Weibin, et al.
Publicado: (2021)

Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
por: Zhang, Ruixue, et al.
Publicado: (2019)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
por: Dong, Q., et al.
Publicado: (2013)

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation
por: Feng, Hui, et al.
Publicado: (2021)

Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation
por: Zhu, Zhongsheng, et al.
Publicado: (2019)

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression
por: Ding, Zufeng, et al.
Publicado: (2013)

Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition
por: Qian, Weibin, et al.
Publicado: (2020)

Expression of LOX-1 in human mesangial cells is increased by Ox-LDL and IL-1β treatment
por: Deng, Yinghui, et al.
Publicado: (2017)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine
por: Zheng, Yangmin, et al.
Publicado: (2023)

K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages
por: Zhou, Zhenfeng, et al.
Publicado: (2020)

Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation
por: Li, Xinhua, et al.
Publicado: (2017)

MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1
por: Chen, Zhibo, et al.
Publicado: (2017)

KAP1 silencing relieves OxLDL-induced vascular endothelial dysfunction by down-regulating LOX-1
por: Yan, Tianqing, et al.
Publicado: (2020)

Interleukin-1β Promotes Ox-LDL Uptake by Human Glomerular Mesangial Cells via LOX-1
por: Liu, Hua, et al.
Publicado: (2020)

Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-κB and CaSR
por: Leng, Bin, et al.
Publicado: (2019)

Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2
por: Xiao, Lan, et al.
Publicado: (2021)

lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial–mesenchymal transition by competitively binding miR-141-3p
por: Qian, Weibin, et al.
Publicado: (2019)

Mechanism of tacrolimus-induced chronic renal fibrosis following transplantation is regulated by ox-LDL and its receptor, LOX-1
por: Deng, Shi, et al.
Publicado: (2016)

Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress
por: Hang, Liwei, et al.
Publicado: (2020)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

Ox-LDL Induces Dysfunction of Endothelial Progenitor Cells via Activation of NF-κB
por: Ji, Kang-ting, et al.
Publicado: (2015)

Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant
por: Falconi, Mattia, et al.
Publicado: (2007)

A fermented bean flour extract downregulates LOX-1, CHOP and ICAM-1 in HMEC-1 stimulated by ox-LDL
por: Gabriele, Morena, et al.
Publicado: (2016)

Metastasis‐associated protein 1 promotes epithelial‐mesenchymal transition in idiopathic pulmonary fibrosis by up‐regulating Snail expression
por: Qian, Weibin, et al.
Publicado: (2020)

Angelica Sinensis Polysaccharide Suppresses Epithelial-Mesenchymal Transition and Pulmonary Fibrosis via a DANCR/AUF-1/FOXO3 Regulatory Axis
por: Qian, Weibin, et al.
Publicado: (2020)

Correction to: Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems
por: Tian, Li, et al.
Publicado: (2020)

Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems
por: Tian, Li, et al.
Publicado: (2019)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling
por: Hung, Ching-Hsia, et al.
Publicado: (2016)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Differential Binding of NLRP3 to non-oxidized and Ox-mtDNA mediates NLRP3 Inflammasome Activation
por: Cabral, Angela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f6mbg605k1ps2oejt05p5m2rpn